Edesa Biotech, Inc.
EDSA
$4.94
-$0.43-8.01%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.53M | 1.22M | 1.24M | 964.70K | 1.15M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.30M | 2.34M | 2.47M | 1.90M | 1.64M |
| Operating Income | -4.30M | -2.34M | -2.47M | -1.90M | -1.64M |
| Income Before Tax | -4.22M | -2.25M | -2.23M | -1.75M | -1.59M |
| Income Tax Expenses | 800.00 | -- | 0.00 | -- | 800.00 |
| Earnings from Continuing Operations | -4.22M | -2.25M | -2.23M | -1.75M | -1.59M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.22M | -2.25M | -2.23M | -1.75M | -1.59M |
| EBIT | -4.30M | -2.34M | -2.47M | -1.90M | -1.64M |
| EBITDA | -4.27M | -2.32M | -2.44M | -1.88M | -1.61M |
| EPS Basic | -0.49 | -0.28 | -0.32 | -0.25 | -0.30 |
| Normalized Basic EPS | -0.31 | -0.18 | -0.22 | -0.17 | -0.19 |
| EPS Diluted | -0.49 | -0.28 | -0.32 | -0.25 | -0.30 |
| Normalized Diluted EPS | -0.31 | -0.18 | -0.22 | -0.17 | -0.19 |
| Average Basic Shares Outstanding | 8.54M | 7.97M | 7.05M | 7.02M | 5.31M |
| Average Diluted Shares Outstanding | 8.61M | 7.97M | 7.05M | 7.02M | 5.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |